Alkaloid AD Skopje operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Alkaloid AD Skopje with three other
pharmaceutical manufacturers in Europe:
Pharming Group NV
sales of 185.69 million Euros [US$225.08 million]
of which 100%
was Recombinant Proteins),
Eurobio Scientific SA
(188.86 million Euros [US$228.92 million]
based in FRANCE
(194.12 million Euros [US$235.29 million]
of which 70%
was Pharmaceutical Synthesis).
During the first
quarter of 2021, sales at Alkaloid AD Skopje totalled
3.27 billion Macedonian Denars.
This is a drop of 2.8%
from the 3.37 billion Macedonian Denars in sales at the company during the first quarter in 2020.
This was the largest quarterly drop in sales since the fourth
quarter of 2014.
Alkaloid AD Skopje reported sales of 12.13 billion Macedonian Denars (US$239.13 million)
December of 2020.
increase of 9.3%
versus 2019, when the company's sales were 11.10 billion Macedonian Denars.
Sales at Alkaloid AD Skopje have increased during each of the previous five years
(and since 2015, sales have increased a total of 54%).
Sales of Chemicals saw an increase
12.2% in 2020, from
257.64 million Macedonian Denars to 289.03 million Macedonian Denars.
Not all segments of Alkaloid AD Skopje experienced an increase in sales in 2020:
sales of Botanicals fell 5.4% to 388.99 million Macedonian Denars.
(However, this segment's sales were only a very small portion of the company's overall sales).